These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2454049)

  • 1. Purification and reconstitution of calcium channel drug-receptor sites.
    Glossmann H; Striessnig J; Hymel L; Schindler H
    Ann N Y Acad Sci; 1988; 522():150-61. PubMed ID: 2454049
    [No Abstract]   [Full Text] [Related]  

  • 2. Photoaffinity labelling of the phenylalkylamine receptor of the skeletal muscle transverse-tubule calcium channel.
    Striessnig J; Knaus HG; Grabner M; Moosburger K; Seitz W; Lietz H; Glossmann H
    FEBS Lett; 1987 Feb; 212(2):247-53. PubMed ID: 2434359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channels: basic properties as revealed by radioligand binding studies.
    Glossmann H; Ferry DR; Goll A; Striessnig J; Schober M
    J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S20-30. PubMed ID: 2414589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 165-kDa peptide of the purified skeletal muscle dihydropyridine receptor contains the known regulatory sites of the calcium channel.
    Sieber M; Nastainczyk W; Zubor V; Wernet W; Hofmann F
    Eur J Biochem; 1987 Aug; 167(1):117-22. PubMed ID: 2441986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Ca2+ antagonists binding protein from cytosolic fraction the precursor of alpha 1-subunit of Ca2+ channel?
    Krizanová O; Hudecová S; Orlický J; Zachar J
    Gen Physiol Biophys; 1989 Apr; 8(2):99-111. PubMed ID: 2550315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular properties of dihydropyridine-sensitive calcium channels.
    Seagar MJ; Takahashi M; Catterall WA
    Ann N Y Acad Sci; 1988; 522():162-75. PubMed ID: 2454051
    [No Abstract]   [Full Text] [Related]  

  • 7. Diazipine, a novel photoaffinity probe for dihydropyridine receptors of calcium channels.
    Taki M; Nakayama H; Kanaoka Y
    FEBS Lett; 1991 Jun; 283(2):259-62. PubMed ID: 1646123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular properties of voltage-activated calcium channels.
    Flockerzi V
    J Protein Chem; 1989 Jun; 8(3):428-30. PubMed ID: 2477023
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of the drug receptors of the purified skeletal muscle calcium channel.
    Striessnig J; Glossmann H
    Prog Clin Biol Res; 1988; 252():35-40. PubMed ID: 2450374
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular properties of structure and regulation of the calcium channel.
    Lazdunski M; Barhanin J; Borsotto M; Cognard C; Cooper C; Coppola T; Fosset M; Galizzi JP; Hosey MM; Mourre C
    Ann N Y Acad Sci; 1988; 522():134-49. PubMed ID: 2454048
    [No Abstract]   [Full Text] [Related]  

  • 11. Photoaffinity-labelling of the calcium-channel-associated 1,4-dihydropyridine and phenylalkylamine receptor in guinea-pig hippocampus. A 195 kDa polypeptide carries both drug receptors and has similarities to the alpha 1 subunit of the purified skeletal-muscle calcium channel.
    Striessnig J; Knaus HG; Glossmann H
    Biochem J; 1988 Jul; 253(1):39-47. PubMed ID: 2844171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular properties of voltage-sensitive calcium channels.
    Catterall WA; Curtis BM
    Soc Gen Physiol Ser; 1987; 41():201-13. PubMed ID: 2436311
    [No Abstract]   [Full Text] [Related]  

  • 13. (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines.
    Reynolds IJ; Snowman AM; Snyder SH
    J Pharmacol Exp Ther; 1986 Jun; 237(3):731-8. PubMed ID: 3012067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereoselective photoaffinity labelling of the purified 1,4-dihydropyridine receptor of the voltage-dependent calcium channel.
    Striessnig J; Moosburger K; Goll A; Ferry DR; Glossmann H
    Eur J Biochem; 1986 Dec; 161(3):603-9. PubMed ID: 2431906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photoaffinity labeling of the calcium channel antagonist receptor in the heart of the cardiomyopathic hamster.
    Kuo TH; Johnson DF; Tsang W; Wiener J
    Biochem Biophys Res Commun; 1987 Nov; 148(3):926-33. PubMed ID: 2446613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between calcium channel ligands and calcium channels.
    Glossmann H; Striessnig J; Ferry DR; Goll A; Moosburger K; Schirmer M
    Circ Res; 1987 Oct; 61(4 Pt 2):I30-6. PubMed ID: 2443273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photoaffinity labeling of the partially purified mitochondrial phenylalkylamine calcium antagonist receptor.
    Zernig G
    Mol Pharmacol; 1992 Dec; 42(6):1010-3. PubMed ID: 1336110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
    Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of dihydropyridine calcium antagonists to membranes from human skeletal muscle.
    Krizanová O; Orlický J; Zachar J
    Gen Physiol Biophys; 1988 Jun; 7(3):324-7. PubMed ID: 2456251
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of binding sites for calcium channel antagonists.
    Nakayama H; Kuniyasu A
    Jpn Heart J; 1996 Sep; 37(5):643-50. PubMed ID: 8973377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.